Early Breast Cancer

Study title





To assess whether adjuvant therapy alone is no worse than adjuvant therapy plus axillary treatment, in terms of axillary recurrence within 5 years.

Eligibility criteria

To be considered for the study you must meet the following criteria:

  • 50 years of age or older
  • Have histologically confirmed breast cancer
  • Nodal involvement
Study details

The study will compare adjuvant therapy alone with adjuvant therapy plus axillary treatment (axillary node clearance (ANC) or axillary radiotherapy (ART)).

Your participation in this study will be for approximately 5 years.

Sign up to this clinical trial below.

Further information